20 Aug, EOD - Indian

SENSEX 80802.86 (0.47)

Nifty 50 24698.85 (0.51)

Nifty Bank 50803.15 (0.86)

Nifty IT 41572.8 (0.81)

Nifty Midcap 100 58247.85 (0.84)

Nifty Next 50 73971.3 (0.82)

Nifty Pharma 22374.25 (0.61)

Nifty Smallcap 100 18839.95 (0.47)

20 Aug, EOD - Global

NIKKEI 225 38062.92 (1.80)

HANG SENG 17511.08 (-0.33)

DOW JONES 40841.44 (-0.15)

S&P 5602.49 (-0.19)

Login/Signup
LOGIN HERE
Cancel

Narayana Hrudayalaya Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 539551 | NSE Symbol : NH | ISIN : INE410P01011 | Industry : Healthcare |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
29-Jul-2024 02-Aug-2024 Quarterly Results Narayana Hrudayalaya Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/08/2024 inter alia to consider and approve the unaudited Standalone and Consolidated Financial Results for the first quarter ended 30th June 2024. Please find enclosed the unaudited financial results for the quarter ended June 30,2024 (As Per BSE Announcement dated on 02.08.2024)
14-Jun-2024 14-Jun-2024 Change in Directors Pursuant to Regulation 30 of SEBI (LODR) Regulation 2015, we hereby inform you that based on the recommendation of Nomination and Remuneration Committee, the Board of Directors of the Company vide Circular Resolution passed on today i.e. 14th June 2024 have appointed Dr. Anesh Shetty as an Additional Director of the Company in the capacity of Non-Executive Non Independent Director w.e.f. 15th June 2024
18-May-2024 24-May-2024 Accounts Narayana Hrudayalaya Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2024 inter alia to consider and approve a) the audited standalone and consolidated financial results of the Company for the quarter and year ended 31st March 2024 b)Recommend dividend on equity shares for the financial year ended 31st March 2024 and c) Consider the proposal to raise money by means of the issue of debt securities on private placement basis in one or more tranches subject to approval of the shareholders in the ensuing Annual General Meeting. The Board in its meeting held on 24th May 2024 has recommended dividend of Rs. 4/- per equity share for the financial year ended 31st March 2024 for the approval of the shareholder in the ensuing annual general meeting of the company. (As Per BSE Announcement Dated on 24.05.2024)
07-Feb-2024 14-Feb-2024 Quarterly Results Narayana Hrudayalaya Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve the unaudited financial results for the quarter and nine months ended December 31 2023 Unaudited Financial Results for the quarter ended December 31, 2023 (As Per BSE Announcement dated on 14.02.2024)
07-Nov-2023 13-Nov-2023 Quarterly Results Narayana Hrudayalaya Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2023 inter alia to consider and approve the unaudited Standalone and Consolidated Financial Results for the quarter and half year ended 30th September 2023. The Board of Directors of the Company at their meeting held on Monday, 13th November 2023, inter alia, considered and approved the Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended 30th September 2023 together with Limited Review Report. The Board of Directors of the company at their meeting held on Monday, 13th November 2023, inter alia, considered and approved the unaudited financial results for the quarter and half year ended 30th September 2023. (As Per BSE Announcement Dated on 13/11/2023)
27-Jul-2023 02-Aug-2023 Quarterly Results Narayana Hrudayalaya Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/08/2023 inter alia to consider and approve the unaudited Standalone and Consolidated Financial Results for the first quarter ended 30th June 2023. NARAYANA HRUDAYALAYA LIMITED has informed BSE about Board Meeting to be held on 02 Aug 2023 to consider financial statements for the period ended June 2023. Financial results. (As Per BSE Announcement Dated on 28.07.2023) Outcome of the Board Meeting to consider and approve the unaudited financial Results for the quarter ended 30th June 2023 (As per BSE Announcement Dated on 02/08/2023)
12-May-2023 19-May-2023 Accounts Narayana Hrudayalaya Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2023 inter alia to consider and approve a)Audited Standalone and Consolidated Financial Results for the quarter and year ended 31st March 2023. b) Recommendation of dividend for the Financial Year ended 31st March 2023. c) Proposal to raise money by means of issue of debt securities on private placement basis in one or more tranches subject to approval of shareholders in the ensuing Annual General Meeting to meet the requirement of funding of 25% of the incremental borrowing in a year as per SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 dated 26th November 2018. This is only to enable the Company to comply with the requirements of the aforesaid SEBI Circular. The Board of Directors has recommended a final dividend of Rs.2.50/- (Rupees Two and Fifty Paise) per share, for the year ended 31st March 2023, for approval of shareholders of the Company at the ensuing Annual General Meeting (AGM). The payment of said dividend will be made within the statutorily prescribed time of 30 days from the date of approval by the Shareholders at the ensuing AGM. This is to inform you that the Board of Directors of the Company at its meeting held today, i.e. 19th May, 2023, inter alia, has approved the following: 1. Audited Financial Results (Standalone and Consolidated) for the Financial Year ended 31st March 2023 together with Auditors' Report thereon, pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'). A copy of the Audited Standalone and Consolidated Financial Results of the Company for the Financial Year 31st March 2023 together with Auditors' Report thereon is enclosed for your information. (As Per BSE Announcement Dated on 19.05.2023)
29-Mar-2023 29-Mar-2023 Change in Directors Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors in its meeting held on 29th March 2023 has inducted Mr. Naveen Tewari (DIN: 00677638) as an Additional Director in the capacity of an Independent Director w.e.f. 29th March 2023. Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors in its meeting held on 29th March 2023 has appointed Mr. Venkatesh R as the Group Chief Operating Officer effective from 1st April 2023. (As Per BSE Announcement dated on 30.03.2023)
02-Feb-2023 08-Feb-2023 Quarterly Results Narayana Hrudayalaya Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2023 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended 31st December 2022.
03-Nov-2022 09-Nov-2022 Quarterly Results Narayana Hrudayalaya Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2022 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results for the second quarter and half year ended 30th September 2022. Outcome of Board meeting held on 9th November 2022 to consider unaudited Financial Results (Standalone and Consolidated) for the Second quarter and half year ended 30th September 2022 together with Limited Review Report has been reviewed by Audit Committee and approved by the Board of Directors. (As Per BSE Announcement Dated on 09/11/2022)
02-Aug-2022 08-Aug-2022 Quarterly Results Narayana Hrudayalaya Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2022 inter alia to consider and approve Unaudited Standalone and Consolidated Financial Results for the first quarter ended 30th June 2022. Outcome of Board meeting held on 8th August 2022, to consider the Unaudited Financial Results (Standalone and Consolidated) for the First Quarter ended 30th June 2022 together with Limited Review Report has been reviewed by Audit Committee and approved by the Board of Directors. (As Per BSE Announcement Dated on 08/08/2022)
13-May-2022 20-May-2022 Dividend Narayana Hrudayalaya Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2022 inter alia to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (SEBI LODR Regulations) this is to inform you that a meeting of the Board of Directors of the Company will be held on Friday 20th May 2022 inter-alia to consider and approve the following: a) Audited Standalone and Consolidated Financial Results for the quarter and year ended 31st March 2022. b) Recommendation of dividend for the Financial Year ended 31st March 2022. c) Proposal to raise money by means of issue of debt securities on private placement basis in one or more tranches subject to approval of shareholders in the ensuing Annual General Meeting to meet the requirement of funding of 25% of the incremental borrowing in a year Narayana Hrudayalaya Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 20, 2022, inter alia, to consider and approve the following: 1. Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2022. 2. Recommendation of dividend for the Financial Year ended March 31, 2022. 3. Proposal to raise money by means of issue of debt securities on private placement basis in one or more tranches subject to approval of shareholders in the ensuing Annual General Meeting to meet the requirement of funding of 25% of the incremental borrowing in a year as per SEBI Circular dated November 26, 2018 as and when the company meets the criteria of a Large Corporate. This is only to enable the Company to comply with the requirements of the aforesaid SEBI Circular as and when the Company meets the criteria of a Large Corporate as defined under the said SEBI Circular. (As Per BSE Announcement dated on 14.05.2022) The Board of Directors have recommended a dividend of Re. 1 (Rupee One) per share, for the year ended 31st March, 2022, for approval of shareholders of the Company at the ensuing Annual General Meeting (AGM). The payment of said dividend will be made within the statutorily prescribed time of 30 days from the date of approval by the Shareholders at the ensuing AGM. The Board also approved and recommended to the shareholders the re-appointment of M/s. Deloitte Haskins & Sells LLP, Chartered Accountants (ICAI Firm Registration Number: 117366W/W-100018), as the Statutory Auditors of the Company for the second term of 5 (five) consecutive years who shall hold the office from the conclusion of the ensuing 22nd Annual General Meeting (AGM) of the Company till the conclusion of the 27th AGM of the Company. This is to inform you that the Board of Directors of the Company at its meeting held today, i.e. 20th May, 2022, inter alia, has approved the following: 1. Audited Financial Results (Standalone and Consolidated) for the Financial Year ended 31st March, 2022 together with Auditors'' Report thereon, pursuant to Regulation 33 of the Securities and Exchange · Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'). 2. We hereby declare that the Statutory Auditors of the Company, M/s. Deloitte Haskins & Sells LLP, have issued an Audit Report with unmodified opinion on Audited Financial Results (Standalone and Consolidated) of the Company for the year ended March 31, 2022. (As per BSE Announcement Dated on 20/5/2022)
30-Mar-2022 29-Mar-2022 Change in Directors A. Appointment of Mr. Viren Prasad Shetty as Executive Vice-Chairman of Narayana Hrudayalaya Ltd. B. Appointment of Dr. Anesh Shetty as the Managing Director of Health City Cayman Islands Ltd. (HCCI), Cayman
28-Jan-2022 04-Feb-2022 Quarterly Results Narayana Hrudayalaya Limited has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2022 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that a meeting of the Board of Directors of the Company will be held on Friday 4th February 2022 inter-alia to consider and approve the Unaudited Standalone and Consolidated Financial Results for the Third quarter ended 31st December 2021. This is to inform you that the Board of Directors of the Company at its meeting held today, i.e. 4th February, 2022, inter alia, has approved the following: l. Unaudited Financial Results (Standalone and Consolidated) for the third Quarter ended 31st December, 2021 together with Auditors'' Limited Review Report, pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'). 2. Re-appointment of Dr. Emmanuel Rupert (DIN: 07010883), based on the recommendations of the Nomination and Remuneration Committee, as the Managing Director and Group CEO of the Company for a period of 3 (three) years with effect from 11th February, 2022 subject to the approval of the Shareholders of the Company by means of a postal ballot through electronic voting. This is to inform you that the Board of Directors of the Company at its meeting held today, i.e. 4th February, 2022, inter alia, has approved the following: l. Unaudited Financial Results (Standalone and Consolidated) for the third Quarter ended 31st December, 2021 together with Auditors'' Limited Review Report, pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'). (As Per BSE Announcement Dated on 04.02.2022) Further to our letter dated 4th February, 2022, we wish to inform you that pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), the Operation and Management Agreement entered between Narayana Health Bangladesh Pvt. Ltd. (NHBD), Bangladesh, step-down subsidiary of the Company and Imperial Hospital Limited (IHL), Bangladesh on 5th February, 2020 for a period of 2 (two) years, to operate and manage the Cardiac Sciences Department of IHL, expires on 4th February, 2022. The step-down subsidiary NHBD has decided not to renew the said agreement and thereby wind up its operations in Chittagong, Bangladesh by end of business hours on 4th February, 2022. (As Per BSE Announcement Dated on 05.02.2022)
03-Nov-2021 10-Nov-2021 Quarterly Results Quarterly Results Outcome of Board Meeting - Financial results for second quarter and half year ended 30th September 2021 Appointment of Chief Financial Officer and Key Managerial Personnel (As Per BSE Announcement Dated on 10/11/2021)
1 2